BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34903507)

  • 1. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
    Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.
    Muehleisen B; Jiang SB; Gladsjo JA; Gerber M; Hata T; Gallo RL
    PLoS One; 2012; 7(7):e40754. PubMed ID: 22808251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
    Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
    Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
    Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours.
    Khorshid SM; Glover MT; Churchill L; McGregor JM; Proby CM
    J Cutan Pathol; 1996 Jun; 23(3):229-33. PubMed ID: 8793657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
    Ng JC; Cumming S; Leung V; Chong AH
    Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
    Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
    Keller B; Braathen LR; Marti HP; Hunger RE
    Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
    Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
    Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
    J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
    J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
    Abikhair Burgo M; Roudiani N; Chen J; Santana AL; Doudican N; Proby C; Felsen D; Carucci JA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.